Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan A Grupp

Showing results (121-130 of 238) with videos related to

Pageof 24
Sort By:
The New England Journal of Medicine|March 27, 2013
Chimeric antigen receptor-modified T cells for acute lymphoid leukemiaStephan A Grupp, Michael Kalos, David Barrett, et al.
Human Gene Therapy|July 20, 2018
Purification of mRNA Encoding Chimeric Antigen Receptor Is Critical for Generation of a Robust T-Cell ResponseJessica B Foster, Namrata Choudhari, Jessica Perazzelli, et al.
Annals of Neurology|September 5, 2018
Neurotoxicity after CTL019 in a pediatric and young adult cohortJacqueline S Gofshteyn, Pamela A Shaw, David T Teachey, et al.
Blood Advances|December 6, 2021
Unrelated donor α/β T cell- and B cell-depleted HSCT for the treatment of pediatric acute leukemiaAllison Barz Leahy, Yimei Li, Julie-An Talano, et al.
Cancer Discovery|April 6, 2021
Integrative Bulk and Single-Cell Profiling of Premanufacture T-cell Populations Reveals Factors Mediating Long-Term Persistence of CAR T-cell TherapyGregory M Chen, Changya Chen, Rajat K Das, et al.
Blood|June 8, 2006
Rapamycin improves lymphoproliferative disease in murine autoimmune lymphoproliferative syndrome (ALPS)David T Teachey, Dana A Obzut, Kelly Axsom, et al.
Leukemia|April 15, 2022
Tisagenlecleucel in pediatric and young adult patients with Down syndrome-associated relapsed/refractory acute lymphoblastic leukemiaTheodore W Laetsch, Shannon L Maude, Adriana Balduzzi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 23, 2009
Chimeric receptors containing CD137 signal transduction domains mediate enhanced survival of T cells and increased antileukemic efficacy in vivoMichael C Milone, Jonathan D Fish, Carmine Carpenito, et al.
Journal for Immunotherapy of Cancer|December 6, 2018
Chimeric antigen receptor (CAR) T therapies for the treatment of hematologic malignancies: clinical perspective and significanceMichael M Boyiadzis, Madhav V Dhodapkar, Renier J Brentjens, et al.
Blood|September 23, 2017
Cellular kinetics of CTL019 in relapsed/refractory B-cell acute lymphoblastic leukemia and chronic lymphocytic leukemiaKaren Thudium Mueller, Shannon L Maude, David L Porter, et al.
Pageof 24

Showing results (121-130 of 238) with videos related to

Sort By:
Pageof 24
The New England Journal of Medicine|March 27, 2013
Chimeric antigen receptor-modified T cells for acute lymphoid leukemiaStephan A Grupp, Michael Kalos, David Barrett, et al.
Human Gene Therapy|July 20, 2018
Purification of mRNA Encoding Chimeric Antigen Receptor Is Critical for Generation of a Robust T-Cell ResponseJessica B Foster, Namrata Choudhari, Jessica Perazzelli, et al.
Annals of Neurology|September 5, 2018
Neurotoxicity after CTL019 in a pediatric and young adult cohortJacqueline S Gofshteyn, Pamela A Shaw, David T Teachey, et al.
Blood Advances|December 6, 2021
Unrelated donor α/β T cell- and B cell-depleted HSCT for the treatment of pediatric acute leukemiaAllison Barz Leahy, Yimei Li, Julie-An Talano, et al.
Cancer Discovery|April 6, 2021
Integrative Bulk and Single-Cell Profiling of Premanufacture T-cell Populations Reveals Factors Mediating Long-Term Persistence of CAR T-cell TherapyGregory M Chen, Changya Chen, Rajat K Das, et al.
Blood|June 8, 2006
Rapamycin improves lymphoproliferative disease in murine autoimmune lymphoproliferative syndrome (ALPS)David T Teachey, Dana A Obzut, Kelly Axsom, et al.
Leukemia|April 15, 2022
Tisagenlecleucel in pediatric and young adult patients with Down syndrome-associated relapsed/refractory acute lymphoblastic leukemiaTheodore W Laetsch, Shannon L Maude, Adriana Balduzzi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 23, 2009
Chimeric receptors containing CD137 signal transduction domains mediate enhanced survival of T cells and increased antileukemic efficacy in vivoMichael C Milone, Jonathan D Fish, Carmine Carpenito, et al.
Journal for Immunotherapy of Cancer|December 6, 2018
Chimeric antigen receptor (CAR) T therapies for the treatment of hematologic malignancies: clinical perspective and significanceMichael M Boyiadzis, Madhav V Dhodapkar, Renier J Brentjens, et al.
Blood|September 23, 2017
Cellular kinetics of CTL019 in relapsed/refractory B-cell acute lymphoblastic leukemia and chronic lymphocytic leukemiaKaren Thudium Mueller, Shannon L Maude, David L Porter, et al.
Pageof 24